Close

Bristol-Myers Squibb (BMY) Announces Research Collaboration with Boston Medical Center to Investigate Markers of Immuno-Oncology Response & Resistance

Go back to Bristol-Myers Squibb (BMY) Announces Research Collaboration with Boston Medical Center to Investigate Markers of Immuno-Oncology Response & Resistance

Bristol-Myers Squibb and Boston Medical Center Announce Research Collaboration to Investigate Markers of Immuno-Oncology Response and Resistance

December 17, 2018 4:30 PM EST

NEW YORK & BOSTON--(BUSINESS WIRE)-- Bristol-Myers Squibb Company (NYSE: BMY), and Boston Medical Center, a private, not-for-profit, academic medical center, today announced a multi-year joint research study to identify and analyze potential... More